Coordinated Assessment of Notifications of Trials Containing Overt Published Errors
Study Details
Study Description
Brief Summary
Clinical research, like all science, is self-correcting, with errors detected by the scientific community and communicated to the publishing journals, which then relay the information (and its resolution) to its readers. If this relaying process fails, science grinds to a halt. In this study we are testing its integrity.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
This prospective study documents the outcome of notification to journal editorial boards (or equivalent authorities) of factually incorrect or inconsistent claims, in reports they have published.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Provision of information Reporting of discrepancy to journal |
Behavioral: Reporting of discrepancy to journal
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Time to correction, retraction, or other notification to the readership of discrepancy [12 months]
Secondary Outcome Measures
- Time to initial response from journal [0-4 weeks]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Report of a clinical trial in humans of treatment of heart disease with bone marrow derived stem cells
-
Report containing discrepancy by reference to same report or another report
Exclusion Criteria:
- Discrepancy has already been corrected by an erratum
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | International Centre for Circulatory Health | London | United Kingdom | W2 1LA |
Sponsors and Collaborators
- Imperial College London
Investigators
- Study Chair: Darrel P Francis, MA MD FRCP, Imperial College London
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
- Francis DP, Mielewczik M, Zargaran D, Cole GD. Autologous bone marrow-derived stem cell therapy in heart disease: discrepancies and contradictions. Int J Cardiol. 2013 Oct 9;168(4):3381-403. doi: 10.1016/j.ijcard.2013.04.152. Epub 2013 Jul 2. Review.
- Nowbar AN, Mielewczik M, Karavassilis M, Dehbi HM, Shun-Shin MJ, Jones S, Howard JP, Cole GD, Francis DP; DAMASCENE writing group. Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis. BMJ. 2014 Apr 28;348:g2688. doi: 10.1136/bmj.g2688. Review.
- ICCH/13/SFI/Str